Loading…

Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma

Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected...

Full description

Saved in:
Bibliographic Details
Published in:American journal of otolaryngology 2011-11, Vol.32 (6), p.464-469
Main Authors: Revenaugh, Peter C., MD, Seth, Rahul, MD, Pavlovich, Justin B., MD, Knott, P. Daniel, MD, Batra, Pete S., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3
cites cdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3
container_end_page 469
container_issue 6
container_start_page 464
container_title American journal of otolaryngology
container_volume 32
creator Revenaugh, Peter C., MD
Seth, Rahul, MD
Pavlovich, Justin B., MD
Knott, P. Daniel, MD
Batra, Pete S., MD
description Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b.
doi_str_mv 10.1016/j.amjoto.2010.09.006
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_901308424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019607091000181X</els_id><sourcerecordid>2730091231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</originalsourceid><addsrcrecordid>eNqFkt-L1DAQgIMo3t7pfyBSELmnrjNNmmxfBDn8BSf3oMK9hTSdQmqbrEm7sP-9Kbt6cC8-BZJvJjPfDGOvELYIKN8NWzMNYQ7bCvIVNFsA-YRtsOZVucPd_VO2AWxkCQqaC3aZ0gAAXPD6ObuoEAQC4IbdfXPeTWYcj4XzB5PcgQryXUg27J0tIiWyswu-CH2RnA_eJDMWi-9c31MkPzszU1dYE21-ncwL9qw3Y6KX5_OK_fz08cfNl_L27vPXmw-3pRVKzCU10tS85cAtWdWaSkgyYFDUtrWNbUgqJTo0iqqqrVFKVSveYc9NKxR2ll-x61PefQy_F0qznlyyNI7GU1iSbgA57EQlMvnmETmEJfpcnEbgqEACrJQ4UTaGlCL1eh-zl3jMkF5960GffOvVt4ZGZ9857PU5-dJO1P0L-is4A2_PgEnWjH003rr0wGUbUvCVe3_iKEs7OIo6WUfeUudinoDugvtfJY8T2DGPNv_5i46UHnrWqdKgv6-7sa5GrhJwh_f8D6WgtUI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031706004</pqid></control><display><type>article</type><title>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</title><source>ScienceDirect Journals</source><creator>Revenaugh, Peter C., MD ; Seth, Rahul, MD ; Pavlovich, Justin B., MD ; Knott, P. Daniel, MD ; Batra, Pete S., MD</creator><creatorcontrib>Revenaugh, Peter C., MD ; Seth, Rahul, MD ; Pavlovich, Justin B., MD ; Knott, P. Daniel, MD ; Batra, Pete S., MD</creatorcontrib><description>Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b.</description><identifier>ISSN: 0196-0709</identifier><identifier>EISSN: 1532-818X</identifier><identifier>DOI: 10.1016/j.amjoto.2010.09.006</identifier><identifier>PMID: 21041001</identifier><identifier>CODEN: AJOTDP</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Biopsy, Needle ; Carcinoma - mortality ; Carcinoma - pathology ; Carcinoma - surgery ; Carcinoma - therapy ; Chemoradiotherapy - methods ; Chemotherapy ; Cohort Studies ; Confidence Intervals ; Disease-Free Survival ; Endoscopy - methods ; Female ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Maxillary Sinus Neoplasms - mortality ; Maxillary Sinus Neoplasms - pathology ; Maxillary Sinus Neoplasms - surgery ; Maxillary Sinus Neoplasms - therapy ; Medical sciences ; Medical treatment ; Middle Aged ; Minimally Invasive Surgical Procedures - methods ; Mortality ; Neoplasm Invasiveness - pathology ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Otolaryngology ; Otorhinolaryngology. Stomatology ; Paranasal Sinus Neoplasms - mortality ; Paranasal Sinus Neoplasms - pathology ; Paranasal Sinus Neoplasms - surgery ; Paranasal Sinus Neoplasms - therapy ; Prognosis ; Radiation therapy ; Retrospective Studies ; Sinuses ; Surgery ; Survival Analysis ; Young Adult</subject><ispartof>American journal of otolaryngology, 2011-11, Vol.32 (6), p.464-469</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</citedby><cites>FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24746431$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21041001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Revenaugh, Peter C., MD</creatorcontrib><creatorcontrib>Seth, Rahul, MD</creatorcontrib><creatorcontrib>Pavlovich, Justin B., MD</creatorcontrib><creatorcontrib>Knott, P. Daniel, MD</creatorcontrib><creatorcontrib>Batra, Pete S., MD</creatorcontrib><title>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</title><title>American journal of otolaryngology</title><addtitle>Am J Otolaryngol</addtitle><description>Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biopsy, Needle</subject><subject>Carcinoma - mortality</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>Carcinoma - therapy</subject><subject>Chemoradiotherapy - methods</subject><subject>Chemotherapy</subject><subject>Cohort Studies</subject><subject>Confidence Intervals</subject><subject>Disease-Free Survival</subject><subject>Endoscopy - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Maxillary Sinus Neoplasms - mortality</subject><subject>Maxillary Sinus Neoplasms - pathology</subject><subject>Maxillary Sinus Neoplasms - surgery</subject><subject>Maxillary Sinus Neoplasms - therapy</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Minimally Invasive Surgical Procedures - methods</subject><subject>Mortality</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Otolaryngology</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Paranasal Sinus Neoplasms - mortality</subject><subject>Paranasal Sinus Neoplasms - pathology</subject><subject>Paranasal Sinus Neoplasms - surgery</subject><subject>Paranasal Sinus Neoplasms - therapy</subject><subject>Prognosis</subject><subject>Radiation therapy</subject><subject>Retrospective Studies</subject><subject>Sinuses</subject><subject>Surgery</subject><subject>Survival Analysis</subject><subject>Young Adult</subject><issn>0196-0709</issn><issn>1532-818X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkt-L1DAQgIMo3t7pfyBSELmnrjNNmmxfBDn8BSf3oMK9hTSdQmqbrEm7sP-9Kbt6cC8-BZJvJjPfDGOvELYIKN8NWzMNYQ7bCvIVNFsA-YRtsOZVucPd_VO2AWxkCQqaC3aZ0gAAXPD6ObuoEAQC4IbdfXPeTWYcj4XzB5PcgQryXUg27J0tIiWyswu-CH2RnA_eJDMWi-9c31MkPzszU1dYE21-ncwL9qw3Y6KX5_OK_fz08cfNl_L27vPXmw-3pRVKzCU10tS85cAtWdWaSkgyYFDUtrWNbUgqJTo0iqqqrVFKVSveYc9NKxR2ll-x61PefQy_F0qznlyyNI7GU1iSbgA57EQlMvnmETmEJfpcnEbgqEACrJQ4UTaGlCL1eh-zl3jMkF5960GffOvVt4ZGZ9857PU5-dJO1P0L-is4A2_PgEnWjH003rr0wGUbUvCVe3_iKEs7OIo6WUfeUudinoDugvtfJY8T2DGPNv_5i46UHnrWqdKgv6-7sa5GrhJwh_f8D6WgtUI</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Revenaugh, Peter C., MD</creator><creator>Seth, Rahul, MD</creator><creator>Pavlovich, Justin B., MD</creator><creator>Knott, P. Daniel, MD</creator><creator>Batra, Pete S., MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</title><author>Revenaugh, Peter C., MD ; Seth, Rahul, MD ; Pavlovich, Justin B., MD ; Knott, P. Daniel, MD ; Batra, Pete S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biopsy, Needle</topic><topic>Carcinoma - mortality</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>Carcinoma - therapy</topic><topic>Chemoradiotherapy - methods</topic><topic>Chemotherapy</topic><topic>Cohort Studies</topic><topic>Confidence Intervals</topic><topic>Disease-Free Survival</topic><topic>Endoscopy - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Maxillary Sinus Neoplasms - mortality</topic><topic>Maxillary Sinus Neoplasms - pathology</topic><topic>Maxillary Sinus Neoplasms - surgery</topic><topic>Maxillary Sinus Neoplasms - therapy</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Minimally Invasive Surgical Procedures - methods</topic><topic>Mortality</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Otolaryngology</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Paranasal Sinus Neoplasms - mortality</topic><topic>Paranasal Sinus Neoplasms - pathology</topic><topic>Paranasal Sinus Neoplasms - surgery</topic><topic>Paranasal Sinus Neoplasms - therapy</topic><topic>Prognosis</topic><topic>Radiation therapy</topic><topic>Retrospective Studies</topic><topic>Sinuses</topic><topic>Surgery</topic><topic>Survival Analysis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Revenaugh, Peter C., MD</creatorcontrib><creatorcontrib>Seth, Rahul, MD</creatorcontrib><creatorcontrib>Pavlovich, Justin B., MD</creatorcontrib><creatorcontrib>Knott, P. Daniel, MD</creatorcontrib><creatorcontrib>Batra, Pete S., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of otolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Revenaugh, Peter C., MD</au><au>Seth, Rahul, MD</au><au>Pavlovich, Justin B., MD</au><au>Knott, P. Daniel, MD</au><au>Batra, Pete S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma</atitle><jtitle>American journal of otolaryngology</jtitle><addtitle>Am J Otolaryngol</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>32</volume><issue>6</issue><spage>464</spage><epage>469</epage><pages>464-469</pages><issn>0196-0709</issn><eissn>1532-818X</eissn><coden>AJOTDP</coden><abstract>Abstract Purpose The purpose of the study was to review a single-institution experience with endoscopic resection of sinonasal undifferentiated carcinoma (SNUC). Materials and Methods Thirteen patients underwent treatment of SNUC between January 2002 and July 2009. Retrospective data were collected including demographics, tumor characteristics, surgical strategy, adjuvant therapies, local and regional recurrence, distant metastasis, overall survival, and disease-free survival. Results The mean age was 51.8 years. The most common tumor stage at presentation was T4 (92%). Seven patients (53%) were treated with minimally invasive endoscopic resection (MIER) with negative intraoperative margins. Endoscopic anterior skull base resection was performed in 5 patients, and endoscopic-assisted bifrontal craniotomy was performed in 1 patient to clear the superior tumor margin. Six patients received pre- or postoperative chemoradiation. One patient underwent palliative chemoradiation, and one patient underwent open craniofacial resection. In the MIER group, simultaneous local and regional recurrence was observed in 1 patient (14%) after 30 months. Distant metastases were observed in 2 other patients (28%) without local or regional recurrence. All 3 patients with recurrences died of their disease. The remaining 4 patients were clinically, endoscopically, and radiographically free of disease, resulting in overall and disease-free survival rates of 57% with mean follow-up of 32.3 months. Conclusions These preliminary data suggest a potential role for MIER in the comprehensive management algorithm of SNUC in appropriately selected patients. Patient outcomes including local and regional recurrence, distant metastases, and overall and disease-free survival were comparable to a treatment strategy using traditional craniofacial resection. Level of evidence 2b.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>21041001</pmid><doi>10.1016/j.amjoto.2010.09.006</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0196-0709
ispartof American journal of otolaryngology, 2011-11, Vol.32 (6), p.464-469
issn 0196-0709
1532-818X
language eng
recordid cdi_proquest_miscellaneous_901308424
source ScienceDirect Journals
subjects Adolescent
Adult
Aged
Biological and medical sciences
Biopsy, Needle
Carcinoma - mortality
Carcinoma - pathology
Carcinoma - surgery
Carcinoma - therapy
Chemoradiotherapy - methods
Chemotherapy
Cohort Studies
Confidence Intervals
Disease-Free Survival
Endoscopy - methods
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Maxillary Sinus Neoplasms - mortality
Maxillary Sinus Neoplasms - pathology
Maxillary Sinus Neoplasms - surgery
Maxillary Sinus Neoplasms - therapy
Medical sciences
Medical treatment
Middle Aged
Minimally Invasive Surgical Procedures - methods
Mortality
Neoplasm Invasiveness - pathology
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Otolaryngology
Otorhinolaryngology. Stomatology
Paranasal Sinus Neoplasms - mortality
Paranasal Sinus Neoplasms - pathology
Paranasal Sinus Neoplasms - surgery
Paranasal Sinus Neoplasms - therapy
Prognosis
Radiation therapy
Retrospective Studies
Sinuses
Surgery
Survival Analysis
Young Adult
title Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T17%3A28%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimally%20invasive%20endoscopic%20resection%20of%20sinonasal%20undifferentiated%20carcinoma&rft.jtitle=American%20journal%20of%20otolaryngology&rft.au=Revenaugh,%20Peter%20C.,%20MD&rft.date=2011-11-01&rft.volume=32&rft.issue=6&rft.spage=464&rft.epage=469&rft.pages=464-469&rft.issn=0196-0709&rft.eissn=1532-818X&rft.coden=AJOTDP&rft_id=info:doi/10.1016/j.amjoto.2010.09.006&rft_dat=%3Cproquest_cross%3E2730091231%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-e96a53b303cec7ba246ea0a145cbc9c9e6774d1a7e22b51667573d1f3ab471dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1031706004&rft_id=info:pmid/21041001&rfr_iscdi=true